Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7862]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer
Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced...
New research reveals the circadian clock influences cell growth, metabolism and tumour progression
New research reveals the circadian clock influences cell growth, metabolism and tumour progression
New study reveals computation-guided approach to suppressing cancer tumour growth
New study reveals computation-guided approach to suppressing cancer tumour growth
Research discovery may help diagnose and treat cancer and brain disorders
Research discovery may help diagnose and treat cancer and brain disorders
Skin cancer cells harness nerve cell gene to drill through and invade new tissues
Skin cancer cells harness nerve cell gene to drill through and invade new tissues
Olaparib for high-risk, early-stage breast cancer approved in Europe
Olaparib for high-risk, early-stage breast cancer approved in Europe
WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab + chemotherapy in mNSCLC
WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab +...
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC
WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...
FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer
FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer
FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer
FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation